title: Study of muscular and ventricular function in dynamic cardiomyoplasty: a ten-year follow-up.
abstract: BACKGROUND
  The basic physiologic principle underlying cardiomyoplasty is long-term electrostimulation of a latissimus dorsi muscle (LDM) wrapped around the heart to obtain a phasic activity that could be integrated with ventricular kinetics. The aim of cardiomyoplasty is to prolong survival and to improve the quality of life of patients with severe chronic and irreversible myocardial failure by improving systolic contraction and correcting diastolic dysfunction.
  
  
  METHODS
  To evaluate the long-term outcome of cardiomyoplasty, we investigated 82 patients electively undergoing this procedure in-our hospital. All patients had severe chronic heart failure that did not respond to optimal medical treatment. Patients had a mean age of 50 +/- 12 years (84% males). The cause of heart failure was ischemic (55%), idiopathic cardiomyopathy (34%), ventricular tumor (6%), and other (5%). The mean follow-up was 4.3 years.
  
  
  RESULTS
  The mean New York Heart Association functional class improved after operation from 3.2 to 1.8. Average radioisotopic left ventricular ejection fraction increased from 17% +/- 6% to 28% +/- 3% (p < 0.05). Stroke volume index increased from 35 +/- 9 to 46 +/- 8 ml/beat/m2 (p < 0.05). The heart size remained stable at long term (evaluated by echo and computed tomography scanning). After cardiomyoplasty the number of successive hospitalizations resulting from congestive heart failure was reduced to 0.4 hospitalizations/patient/year (before operation 2.5, p < 0.05). Computed tomography scans showed at long-term a preserved LDM structure in 82% of patients who underwent operation. Survival probability at 7 years was 54% for the totality of patients, and 66% for patients who underwent operation in New York Heart Association functional class 3. Five patients underwent heart transplantation after cardiomyoplasty (mean delay 29 months), principally as a result of the natural evolution of their underlying heart disease, without major technical difficulties.
  
  
  CONCLUSIONS
  Our 10-year clinical experience demonstrates that cardiomyoplasty increases ejection fraction, improves functional class, and ameliorates quality of life. Ventricular volumes and diameters remain stable long term. LDM structure is maintained long term if electrostimulation is performed avoiding excessive myostimulation. Patient selection is the most important determinant for early and late outcome. Late death in patients undergoing cardiomyoplasty is principally due to sudden death. Our future aim is to incorporate a cardioverter-defibrillator in the cardiomyostimulator, thus improving long-term results. Cardiomyoplasty may delay or prevent end-stage heart failure and the need for heart transplantation.
authors.affiliation: Department of Cardiovascular Surgery, Broussais Hospital, Paris, France.
authors.forename: J C
authors.initials: JC
authors.lastname: Chachques
authors.forename: A
authors.initials: A
authors.lastname: Berrebi
authors.forename: A
authors.initials: A
authors.lastname: Hernigou
authors.forename: A
authors.initials: A
authors.lastname: Cohen-Solal
authors.forename: T
authors.initials: T
authors.lastname: Lavergne
authors.forename: J P
authors.initials: JP
authors.lastname: Marino
authors.forename: N
authors.initials: N
authors.lastname: D'Attellis
authors.forename: D
authors.initials: D
authors.lastname: Bensasson
authors.forename: A
authors.initials: A
authors.lastname: Carpentier
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D002306:Cardiac Volume / Q000502:physiology; D018421:Cardiomyoplasty / Q000295:instrumentation; D005260:Female; D005500:Follow-Up Studies; D006333:Heart Failure / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000601:surgery*; D016027:Heart Transplantation / Q000502:physiology; D006439:Hemodynamics / Q000502:physiology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000502:physiology*; D011183:Postoperative Complications / Q000401:mortality / Q000503:physiopathology*; D013318:Stroke Volume / Q000502:physiology; D013525:Surgical Instruments; D015996:Survival Rate; D013536:Suture Techniques / Q000295:instrumentation; D016277:Ventricular Function, Left / Q000502:physiology*